State-based surveillance for selected hemoglobinopathies

Genetics in Medicine

Volumn 17, Issue 2, 2015, Pages 125-130

  Hulihan, Mary M ^a   Feuchtbaum, Lisa ^b   Jordan, Lanetta ^c   Kirby, Russell S ^d   Snyder, Angela ^e   Young, William ^f   Greene, Yvonne ^g   Telfair, Joseph ^h   Wang, Ying ⁱ   Cramer, William ^j   Werner, Ellen M ^k   Kenney, Kristy ^a   Creary, Melissa ^a   Grant, Althea M ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e GEORGIA STATE UNIVERSITY   (United States)

^f MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^g NORTH CAROLINA DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^h GEORGIA SOUTHERN UNIVERSITY   (United States)

ⁱ NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^j PENNSYLVANIA DEPARTMENT OF HEALTH   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

Hemoglobinopathies; Newborn screening; Sickle cell disease; Surveillance; Thalassemia

Indexed keywords

AFRICAN AMERICAN; AGE DISTRIBUTION; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; BLACK PERSON; DATA COLLECTION METHOD; DISEASE SURVEILLANCE; ETHNIC DIFFERENCE; FEMALE; HEMOGLOBIN H DISEASE; HEMOGLOBIN SC DISEASE; HEMOGLOBINOPATHY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; RACE DIFFERENCE; SEX DIFFERENCE; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; STATE BASED SURVEILLANCE SYSTEM; THALASSEMIA; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; UNITED STATES; ANEMIA, SICKLE CELL; GENETICS; HEALTH SURVEY; HEMOGLOBINOPATHIES; PREVALENCE; REGISTER;

ANEMIA, SICKLE CELL; FEMALE; HEMOGLOBINOPATHIES; HUMANS; MALE; POPULATION SURVEILLANCE; PREVALENCE; REGISTRIES; THALASSEMIA; UNITED STATES;

EID: 84961290948     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.81     Document Type: Article

References (10)

1. Therrell BL, Hannon WH. National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev 2006;12:236-245.
2. Hoppe CC. Newborn screening for hemoglobin disorders. Hemoglobin 2011;35:556-564.
3. Benson JM, Therrell BL Jr. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol 2010;34:134-144.
4. Hassell K, Pace B, Wang W, et al.; American Society of Pediatric Hematology Oncology. Sickle cell disease summit: from clinical and research disparity to action. Am J Hematol 2009;84:39-45.
5. Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med 2008;148:932-938.
6. Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol 2010;85:77-78.
7. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38(suppl 4):S512-S521.
8. Stein DM, Flum AS, Cashy J, Zhao LC, McVary KT. Nationwide emergency department visits for priapism in the United States. J Sex Med 2013;10:2418-2422.
9. Panepinto JA, Owens PL, Mosso AL, Steiner CA, Brousseau DC. Concentration of hospital care for acute sickle cell disease-related visits. Pediatr Blood Cancer 2012;59:685-689.
10. Wolfson JA, Schrager SM, Coates TD, Kipke MD. Sickle-cell disease in California: a population-based description of emergency department utilization. Pediatr Blood Cancer 2011;56:413-419.